Metformin for Treatment of Multiple Sclerosis and Graft-versus-host Disease
Metformin prevents the production of reactive oxygen species (ROS) of mitochondrial complex I. Consequently the expression of CD95 (Fas) ligand is blocked leading to the inhibition of activation-induced T-cell death (AICD). Thus undesirable T-cell death can be inhibited by metformin. Therefore metformin can be used for the treatment of T-cell mediated inflammatory diseases like multiple sclerosis and graft-versus-host disease.
Further Information: PDF
DKFZ (German Cancer Research Center, Deutsches Krebsforschungszentrum)
Phone: +49-6221-42 2955
Contact
Dr. Ruth Herzog
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Superradiant atoms could push the boundaries of how precisely time can be measured
Superradiant atoms can help us measure time more precisely than ever. In a new study, researchers from the University of Copenhagen present a new method for measuring the time interval,…
Ion thermoelectric conversion devices for near room temperature
The electrode sheet of the thermoelectric device consists of ionic hydrogel, which is sandwiched between the electrodes to form, and the Prussian blue on the electrode undergoes a redox reaction…
Zap Energy achieves 37-million-degree temperatures in a compact device
New publication reports record electron temperatures for a small-scale, sheared-flow-stabilized Z-pinch fusion device. In the nine decades since humans first produced fusion reactions, only a few fusion technologies have demonstrated…
